111 related articles for article (PubMed ID: 3683715)
1. Clinical trials in migraine: parallel versus crossover studies.
Kunkel RS
Neuroepidemiology; 1987; 6(4):209-13. PubMed ID: 3683715
[TBL] [Abstract][Full Text] [Related]
2. Migraine trials: crossover or parallel group?
Lewis JA
Neuroepidemiology; 1987; 6(4):198-208. PubMed ID: 3683714
[TBL] [Abstract][Full Text] [Related]
3. Methodology of drug trials in migraine.
Tfelt-Hansen P; Nielsen SL
Funct Neurol; 1986; 1(4):499-502. PubMed ID: 3609877
[TBL] [Abstract][Full Text] [Related]
4. Patient numbers needed in prophylactic migraine trials.
Tfelt-Hansen P; Nielsen SL
Neuroepidemiology; 1987; 6(4):214-9. PubMed ID: 3683716
[TBL] [Abstract][Full Text] [Related]
5. Methodologic issues in acute migraine clinical trials.
Lipton RB
Neurology; 2000; 55(9 Suppl 2):S3-7. PubMed ID: 11089512
[TBL] [Abstract][Full Text] [Related]
6. Selection of patients for clinical drug trials in migraine.
Solomon S
Neuroepidemiology; 1987; 6(4):164-71. PubMed ID: 3317096
[TBL] [Abstract][Full Text] [Related]
7. Controlled trials in pediatric migraine: crossover versus parallel group.
Evers S
Curr Pain Headache Rep; 2007 Jun; 11(3):241-4. PubMed ID: 17504653
[TBL] [Abstract][Full Text] [Related]
8. [Controlled therapeutic trials in migraine: methodology and results].
Baron JC; Bousser MG
Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
[TBL] [Abstract][Full Text] [Related]
9. Methodological aspects of prophylactic drug trials in migraine.
Olesen J; Krabbe AA; Tfelt-Hansen P
Cephalalgia; 1981 Sep; 1(3):127-41. PubMed ID: 7346180
[TBL] [Abstract][Full Text] [Related]
10. Selection of patients--critical aspects.
Diamond S; Solomon GD; Freitag FG; Mehta N
Neuroepidemiology; 1987; 6(4):172-7. PubMed ID: 3317097
[TBL] [Abstract][Full Text] [Related]
11. Methodological aspects of drug trials in migraine.
Tfelt-Hansen P; Olesen J
Neuroepidemiology; 1985; 4(4):204-26. PubMed ID: 2872606
[TBL] [Abstract][Full Text] [Related]
12. Placebo effect and clinical trials in migraine therapy.
Couch JR
Neuroepidemiology; 1987; 6(4):178-85. PubMed ID: 3317098
[TBL] [Abstract][Full Text] [Related]
13. Multi-centre versus single-centre trials in migraine.
Hedman C; Andersen AR; Olesen J
Neuroepidemiology; 1987; 6(4):190-7. PubMed ID: 3683713
[TBL] [Abstract][Full Text] [Related]
14. Prospective study designs in outcomes research: the case of migraine.
Rothermich EA; Brod MI; Schonfeld WH; Rowland CR; Gomez-Mancilla B
Pharmacoeconomics; 2002; 20(11):715-25. PubMed ID: 12201791
[TBL] [Abstract][Full Text] [Related]
15. Drug trials in migraine. The clinician's view on end points.
Bousser MG; Baron JC
Neuroepidemiology; 1987; 6(4):228-33. PubMed ID: 3683718
[TBL] [Abstract][Full Text] [Related]
16. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.
Dodick DW; Turkel CC; DeGryse RE; Diener HC; Lipton RB; Aurora SK; Nolan ME; Silberstein SD
J Pain; 2015 Feb; 16(2):164-75. PubMed ID: 25464159
[TBL] [Abstract][Full Text] [Related]
17. Combining proof-of-concept with dose-finding: utilization of adaptive designs in migraine clinical trials.
Sagkriotis A; Scholpp J
Cephalalgia; 2008 Aug; 28(8):805-12. PubMed ID: 18513264
[TBL] [Abstract][Full Text] [Related]
18. Early-phase clinical trials in migraine: efficacy, safety and dose-finding.
Pilgrim AJ
Cephalalgia; 1995 Oct; 15 Suppl 15():10-3. PubMed ID: 8749240
[TBL] [Abstract][Full Text] [Related]
19. [Methodology of clinical trials in migraine: a rating system].
Tzourio C; Massiou H; Bousser MG
Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821
[TBL] [Abstract][Full Text] [Related]
20. Pirprofen in the treatment of migraine and episodic headache attacks: a placebo-controlled crossover clinical trial.
Guidotti M; Zanasi S; Garagiola U
J Int Med Res; 1989; 17(1):48-54. PubMed ID: 2651177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
